Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Go

Showing results (431-440 of 1,168) with videos related to

Pageof 117
Sort By:
Leukemia Research|October 21, 2022
Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM)Haris Hatic, Shealeigh Inselman, Jonathan Inselman, et al.
British Journal of Haematology|June 28, 2017
Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomesGaurav Goyal, Mithun V Shah, Christopher C Hook, et al.
Medical Care|March 15, 2023
Approach to Multimorbidity Burden Classification and Outcomes in Older Adults With Heart FailureMayra Tisminetzky, Jerry H Gurwitz, Grace Tabada, et al.
The Neurologist|August 15, 2023
Recurrent Tumefactive Central Nervous System Lesions Due to BRIP1 -Related Fanconi AnemiaNabeela Nathoo, Ralitza H Gavrilova, Jorge A Trejo-Lopez, et al.
Scientific Reports|May 31, 2023
The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney diseaseJesse K Fitzpatrick, Rishi V Parikh, Steven A Hamilton, et al.
The American Journal of Cardiology|December 3, 2014
Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts)Jeffrey M Ashburner, Alan S Go, Kristi Reynolds, et al.
The American Journal of Medicine|September 4, 2022
Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and MultimorbidityMayra Tisminetzky, Jerry H Gurwitz, Grace Tabada, et al.
Clinical Chemistry|November 7, 2009
Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicitiesKarsten Sydow, Stephen P Fortmann, Joan M Fair, et al.
Journal of the American Heart Association|June 21, 2013
A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk scoreDaniel E Singer, Yuchiao Chang, Leila H Borowsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 5, 2016
Measurement Error as Alternative Explanation for the Observation that CrCl/GFR Ratio is Higher at Lower GFRXuehan Zhang, Charles E McCulloch, Feng Lin, et al.
Pageof 117

Showing results (431-440 of 1,168) with videos related to

Sort By:
Pageof 117
Leukemia Research|October 21, 2022
Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM)Haris Hatic, Shealeigh Inselman, Jonathan Inselman, et al.
British Journal of Haematology|June 28, 2017
Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomesGaurav Goyal, Mithun V Shah, Christopher C Hook, et al.
Medical Care|March 15, 2023
Approach to Multimorbidity Burden Classification and Outcomes in Older Adults With Heart FailureMayra Tisminetzky, Jerry H Gurwitz, Grace Tabada, et al.
The Neurologist|August 15, 2023
Recurrent Tumefactive Central Nervous System Lesions Due to BRIP1 -Related Fanconi AnemiaNabeela Nathoo, Ralitza H Gavrilova, Jorge A Trejo-Lopez, et al.
Scientific Reports|May 31, 2023
The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney diseaseJesse K Fitzpatrick, Rishi V Parikh, Steven A Hamilton, et al.
The American Journal of Cardiology|December 3, 2014
Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts)Jeffrey M Ashburner, Alan S Go, Kristi Reynolds, et al.
The American Journal of Medicine|September 4, 2022
Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and MultimorbidityMayra Tisminetzky, Jerry H Gurwitz, Grace Tabada, et al.
Clinical Chemistry|November 7, 2009
Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicitiesKarsten Sydow, Stephen P Fortmann, Joan M Fair, et al.
Journal of the American Heart Association|June 21, 2013
A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk scoreDaniel E Singer, Yuchiao Chang, Leila H Borowsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 5, 2016
Measurement Error as Alternative Explanation for the Observation that CrCl/GFR Ratio is Higher at Lower GFRXuehan Zhang, Charles E McCulloch, Feng Lin, et al.
Pageof 117